HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gabriel Olveira Selected Research

Cystic Fibrosis (Mucoviscidosis)

2/2020Oxidative and inflammatory effects of pulmonary rehabilitation in patients with bronchiectasis. A prospective, randomized study.
6/2017Inflammation and Oxidation Biomarkers in Patients with Cystic Fibrosis: The Influence of Azithromycin.
10/2016Oral supplement enriched in HMB combined with pulmonary rehabilitation improves body composition and health related quality of life in patients with bronchiectasis (Prospective, Randomised Study).
12/2012Fat-free mass depletion and inflammation in patients with bronchiectasis.
2/2010Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis.
8/2006Serum phospholipid fatty acid profile and dietary intake in an adult Mediterranean population with cystic fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gabriel Olveira Research Topics

Disease

10Obesity
03/2022 - 10/2007
7Bronchiectasis
03/2021 - 12/2012
6Type 2 Diabetes Mellitus (MODY)
03/2022 - 09/2006
6Hypoglycemia (Reactive Hypoglycemia)
11/2021 - 01/2015
6Hyperglycemia
06/2020 - 05/2013
6Cystic Fibrosis (Mucoviscidosis)
02/2020 - 08/2006
5Inflammation (Inflammations)
01/2020 - 02/2010
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2019 - 10/2003
4Diabetes Mellitus
12/2020 - 11/2003
4Intestinal Failure
10/2020 - 07/2017
4Glucose Intolerance
10/2013 - 09/2006
3Gestational Diabetes (Gestational Diabetes Mellitus)
11/2021 - 04/2010
3Critical Illness (Critically Ill)
01/2021 - 05/2013
3Prediabetic State (Prediabetes)
01/2020 - 01/2015
3Insulin Resistance
05/2019 - 09/2006
2Weight Loss (Weight Reduction)
04/2022 - 01/2021
2Hypertension (High Blood Pressure)
03/2022 - 07/2009
2Hypertriglyceridemia
03/2022 - 10/2015
2Liver Diseases (Liver Disease)
10/2020 - 11/2016
2Fibrosis (Cirrhosis)
01/2020 - 12/2012
2Malnutrition (Nutritional Deficiencies)
09/2019 - 12/2012
2Neoplasms (Cancer)
09/2019 - 06/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2019 - 11/2016
2Exocrine Pancreatic Insufficiency
05/2008 - 08/2006
1Dyslipidemias (Dyslipidemia)
03/2022
1Vitamin B 12 Deficiency (Vitamin B12 Deficiency)
03/2022
1Short Bowel Syndrome
12/2021
1Thyroid Diseases (Thyroid Disease)
12/2021
1Thyroid Hormone Resistance Syndrome (Thyroid Hormone Resistance)
12/2021
1Jaundice (Icterus)
11/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2021
1Gestational Weight Gain
11/2021
1Colic (Abdominal Cramps)
10/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
10/2020
1Sepsis (Septicemia)
10/2020
1Non-alcoholic Fatty Liver Disease
01/2020
1Hyperinsulinism (Hyperinsulinemia)
01/2020
1Body Weight (Weight, Body)
01/2020
1Vitamin D Deficiency
01/2019
1Necrosis
06/2017
1Brain Diseases (Brain Disorder)
11/2016
1Diarrhea
11/2016
1Constipation
11/2016

Drug/Important Bio-Agent (IBA)

10Insulin (Novolin)FDA Link
11/2021 - 04/2010
10Glucose (Dextrose)FDA LinkGeneric
01/2020 - 10/2003
5Biomarkers (Surrogate Marker)IBA
01/2021 - 02/2013
4Insulin Glargine (Lantus)FDA Link
01/2021 - 11/2015
3CholesterolIBA
03/2022 - 10/2003
3Hypoglycemic Agents (Hypoglycemics)IBA
11/2021 - 01/2017
3beta-hydroxyisovaleric acid (beta-hydroxy-beta-methylbutyrate)IBA
02/2020 - 01/2016
3Triglycerides (Triacylglycerol)IBA
01/2020 - 10/2003
3Anti-Bacterial Agents (Antibiotics)IBA
06/2017 - 02/2010
3Blood Glucose (Blood Sugar)IBA
01/2015 - 05/2013
3Fatty Acids (Saturated Fatty Acids)IBA
07/2014 - 08/2006
2Type A Botulinum Toxins (Botox)FDA Link
04/2022 - 01/2021
2Vitamin DFDA LinkGeneric
03/2022 - 01/2019
2HDL CholesterolIBA
03/2022 - 07/2009
2CarbohydratesIBA
06/2020 - 05/2013
2LipidsIBA
06/2020 - 05/2013
2AdipokinesIBA
11/2018 - 12/2012
2Interleukin-6 (Interleukin 6)IBA
06/2017 - 12/2012
2EnzymesIBA
07/2014 - 05/2008
2Phospholipids (Phosphatides)FDA LinkGeneric
02/2010 - 08/2006
1mesoglycanIBA
12/2021
1Pharmaceutical PreparationsIBA
12/2021
1MicroRNAs (MicroRNA)IBA
12/2021
1AntibodiesIBA
12/2021
1Thyroid HormonesIBA
12/2021
1Metformin (Glucophage)FDA LinkGeneric
11/2021
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
03/2021
1goblet cell silencer inhibitorIBA
01/2021
1Urea (Carbamide)FDA LinkGeneric
06/2020
1CannabinoidsIBA
01/2020
1CannabidiolIBA
01/2020
14-(3-3,4-p-menthadien-(1,8)-yl)olivetolIBA
01/2020
1ORALIT (ORS)IBA
05/2019
1Biological ProductsIBA
01/2019
1ElectrolytesIBA
01/2018
1Botulinum Toxins (Botulinum Toxin)IBA
11/2017
1Azithromycin (Zithromax)FDA LinkGeneric
06/2017
1AntioxidantsIBA
06/2017
1Glutathione PeroxidaseIBA
06/2017
1IsoprostanesIBA
06/2017
1MacrolidesIBA
06/2017
1CatalaseIBA
06/2017
1Proteins (Proteins, Gene)FDA Link
06/2017
1Superoxide DismutaseIBA
06/2017
1Thiobarbituric Acid Reactive SubstancesIBA
06/2017

Therapy/Procedure

7Total Parenteral Nutrition
01/2021 - 05/2013
4Therapeutics
12/2021 - 05/2013
4Glycemic Control
11/2021 - 01/2017
4Parenteral Nutrition
06/2020 - 05/2013
4Length of Stay
09/2019 - 11/2003
3Enteral Nutrition (Feeding, Tube)
12/2020 - 10/2003
3Home Parenteral Nutrition
01/2020 - 07/2017
3Injections
01/2017 - 04/2010
2Bariatric Surgery
04/2022 - 01/2021
1Jejunostomy
10/2021
1Catheters
10/2020
1Critical Care (Surgical Intensive Care)
11/2016